| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 676591 | Null | 0.024108502230778 | 0.58250201 |
| NSC 682864 | Null | 0.024108502230778 | 0.44855107 |
| NSC 684836 | Butanamide, N-[2-[(4-fluorophenyl)amino]-1,1,1,3,3,3- hexafluoro-2-propyl]- | 0.024108502230778 | 0.3709086 |
| NSC 685014 | Null | 0.024108502230778 | 0.44047509 |
| NSC 693620 | Null | 0.024108502230778 | 0.34097009 |
| NSC 710334 | Null | 0.024108502230778 | 0.42867065 |
| NSC 722222 | Null | 0.024108502230778 | 0.35620542 |
| NSC 735318 | Null | 0.024108502230778 | 0.40810434 |
| NSC 744025 | diethyl 2-[4-(5-[(11aS)-7-methoxy-5-oxo-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-8-yl]oxypentyl)piperazino]ethylphosphonate | 0.024108502230778 | 0.41688599 |
| NSC 79563 | 1,3-bis(4-chlorobenzyl)-2-(phenanthren-9-yl)hexahydropyrimidine | 0.024108502230778 | 0.35634471 |